Matboli et al. (24) intended to investigate the mechanism for the effect of isorhamnetin that regulates the route of insulin signaling, and demonstrated that through altering the insulin resistance signaling pathway-related RNA network, isorhamnetin might be utilized as an prospective supplemental therapy in T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.